sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Peptide Therapeutics

Peptide Therapeutics Market By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, and Others), By Type (Generic and Innovative), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), By Type of Manufacturers (In-house and Outsourced), By Application (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Mar-2020
  • Total Pages: 181
  • Report Code: FAF-868
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Peptide Therapeutics industry. The report analyzes and declares the historical and current trends analysis of the Peptide Therapeutics industry and subsequently recommends the projected trends anticipated to be observed in the global Peptide Therapeutics market during the upcoming years.

The Peptide Therapeutics market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Peptide Therapeutics market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Billion) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Peptide Therapeutics industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Peptide Therapeutics industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the global Peptide Therapeutics market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Peptide Therapeutics industry. The Peptide Therapeutics market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Peptide Therapeutics sector. Key strategic developments in the global Peptide Therapeutics market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the global Peptide Therapeutics market are appropriately highlighted in the report.

Peptides are formed by combing two or more amino acid monomers using amide bonds. The peptides attach to the specific cell surface receptors to help treat diseases. The peptides were earlier used in diagnostics and hormonal therapy but now it has extensive therapeutic applications of cancer and chronic metabolic diseases.

The growth factor for the demand of the peptide-based therapeutics is the sedentary lifestyle and unhealthy diet that has increased the occurrences of chronic diseases. Furthermore, the growing geriatric population which is prone to various chronic conditions is anticipated to fuel the growth of the global Peptide Therapeutics market. The increasing incidences of cancer and the adverse effects of chemotherapy or radiotherapies help increase the demand for the peptide therapeutics across the globe. Apart from this, the technological advancements and adoption of hybrid technologies help lower costs of peptide therapeutics. The high efficiency and low side effects are the major reason for its high prescription rate. However, the high expenditure on the discovery and development of new therapeutics, off-patent concept, presence of generic or biosimilar peptide therapeutic drugs are likely to hamper the valuation of the global Peptide Therapeutics market. Initiatives by governing bodies and regulatory agencies for the availability of generic and biosimilars owing to their low cost are likely to have an impact on global peptide therapeutics market.

The global Peptide Therapeutics market research report delivers an acute valuation and taxonomy of the Peptide Therapeutics industry by practically splitting the market on the basis of different routes of administration, type, synthesis technology, type of manufacturers, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Peptide Therapeutics industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Peptide Therapeutics industry is provided for the leading economies of the world.

The global Peptide Therapeutics market is segmented based on Route of Administration, Type, Synthesis Technology, Type of Manufacturers, and Application. By route of administration, the market is segmented into Parenteral Route, Oral Route, Pulmonary, Mucosal, and Others. On the basis of type, the global Peptide Therapeutics market is sectored into Generic and Innovative. Based on synthesis technology, the market for peptide therapeutics is divided into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology. In terms of the type of manufacturers, the market is categorized into In-house and Outsourced. In terms of application, the market is classified into Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal, and Others.

Some of the essential players operating in the global Peptide Therapeutics market, but not restricted to include Novartis AG, Eli Lilly and Company, Amgen, Inc., Pfizer, Inc., Lonza Inc., Teva Pharmaceuticals Industries Ltd., Sanofi, GlaxoSmithKline plc., Bristol-Myers Squibb, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, and Novo Nordisk A/S.

The taxonomy of the Peptide Therapeutics industry by its scope and segmentation is as follows:

Global Peptide Therapeutics Market: Type Outlook Segmentation Analysis

  • Generic
  • Innovative

Global Peptide Therapeutics Market: Type of Manufacturers Outlook Segmentation Analysis

  • In-house
  • Outsourced

Global Peptide Therapeutics Market: Route of Administration Outlook Segmentation Analysis

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

Global Peptide Therapeutics Market: Synthesis Technology Segmentation Analysis

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

Global Peptide Therapeutics Market: Application Segmentation Analysis

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Cancer
  • Others

Global Peptide Therapeutics Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Peptide Therapeutics market – Type Analysis
    1. 2.1. Global Peptide Therapeutics Market – Type Overview
    2. 2.2. Global Peptide Therapeutics Market Share, by Type, 2018 & 2025 (USD Million)
    3. 2.3. Generic
      1. 2.3.1. Global Generic Peptide Therapeutics Market, 2016-2026 (USD Million)
    4. 2.4. Innovative
      1. 2.4.1. Global Innovative Peptide Therapeutics Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Peptide Therapeutics market – Type of Manufacturers Analysis
    1. 3.1. Global Peptide Therapeutics Market – Type of Manufacturers Overview
    2. 3.2. Global Peptide Therapeutics Market Share, by Type of Manufacturers, 2018 & 2025 (USD Million)
    3. 3.3. In-house
      1. 3.3.1. Global In-house Peptide Therapeutics Market, 2016-2026 (USD Million)
    4. 3.4. Outsourced
      1. 3.4.1. Global Outsourced Peptide Therapeutics Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Peptide Therapeutics market – Route of Administration Analysis
    1. 4.1. Global Peptide Therapeutics Market – Route of Administration Overview
    2. 4.2. Global Peptide Therapeutics Market Share, by Route of Administration, 2018 & 2025 (USD Million)
    3. 4.3. Parenteral Route
      1. 4.3.1. Global Parenteral Route Peptide Therapeutics Market, 2016-2026 (USD Million)
    4. 4.4. Oral Route
      1. 4.4.1. Global Oral Route Peptide Therapeutics Market, 2016-2026 (USD Million)
    5. 4.5. Pulmonary
      1. 4.5.1. Global Pulmonary Peptide Therapeutics Market, 2016-2026 (USD Million)
    6. 4.6. Mucosal
      1. 4.6.1. Global Mucosal Peptide Therapeutics Market, 2016-2026 (USD Million)
    7. 4.7. Others
      1. 4.7.1. Global Others Peptide Therapeutics Market, 2016-2026 (USD Million)
  5. CHAPTER 5. Peptide Therapeutics market – Synthesis Technology Analysis
    1. 5.1. Global Peptide Therapeutics Market – Synthesis Technology Overview
    2. 5.2. Global Peptide Therapeutics Market Share, by Synthesis Technology, 2018 & 2025 (USD Million)
    3. 5.3. Solid Phase Peptide Synthesis (SPPS)
      1. 5.3.1. Global Solid Phase Peptide Synthesis (SPPS) Peptide Therapeutics Market, 2016-2026 (USD Million)
    4. 5.4. Liquid Phase Peptide Synthesis (LPPS)
      1. 5.4.1. Global Liquid Phase Peptide Synthesis (LPPS) Peptide Therapeutics Market, 2016-2026 (USD Million)
    5. 5.5. Hybrid Technology
      1. 5.5.1. Global Hybrid Technology Peptide Therapeutics Market, 2016-2026 (USD Million)
  6. CHAPTER 6. Peptide Therapeutics market – Application Analysis
    1. 6.1. Global Peptide Therapeutics Market – Application Overview
    2. 6.2. Global Peptide Therapeutics Market Share, by Application, 2018 & 2025 (USD Million)
    3. 6.3. Metabolic
      1. 6.3.1. Global Metabolic Peptide Therapeutics Market, 2016-2026 (USD Million)
    4. 6.4. Cardiovascular Disorder
      1. 6.4.1. Global Cardiovascular Disorder Peptide Therapeutics Market, 2016-2026 (USD Million)
    5. 6.5. Respiratory
      1. 6.5.1. Global Respiratory Peptide Therapeutics Market, 2016-2026 (USD Million)
    6. 6.6. GIT
      1. 6.6.1. Global GIT Peptide Therapeutics Market, 2016-2026 (USD Million)
    7. 6.7. Anti-infection
      1. 6.7.1. Global Anti-infection Peptide Therapeutics Market, 2016-2026 (USD Million)
    8. 6.8. Pain
      1. 6.8.1. Global Pain Peptide Therapeutics Market, 2016-2026 (USD Million)
    9. 6.9. Dermatology
      1. 6.9.1. Global Dermatology Peptide Therapeutics Market, 2016-2026 (USD Million)
    10. 6.10. CNS
      1. 6.10.1. Global CNS Peptide Therapeutics Market, 2016-2026 (USD Million)
    11. 6.11. Renal
      1. 6.11.1. Global Renal Peptide Therapeutics Market, 2016-2026 (USD Million)
    12. 6.12. Cancer
      1. 6.12.1. Global Cancer Peptide Therapeutics Market, 2016-2026 (USD Million)
    13. 6.13. Others
      1. 6.13.1. Global Others Peptide Therapeutics Market, 2016-2026 (USD Million)
  7. CHAPTER 7. Peptide Therapeutics market – Regional Analysis
    1. 7.1. Global Peptide Therapeutics Market Regional Overview
    2. 7.2. Global Peptide Therapeutics Market Share, by Region, 2018 & 2025 (Value)
    3. 7.3. North America
      1. 7.3.1. North America Peptide Therapeutics Market size and forecast, 2016-2026
      2. 7.3.2. North America Peptide Therapeutics Market, by Country, 2018 & 2025 (USD Million)
      3. 7.3.3. North America Peptide Therapeutics Market, by Type, 2016-2026
        1. 7.3.3.1. North America Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
      4. 7.3.4. North America Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026
        1. 7.3.4.1. North America Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
      5. 7.3.5. North America Peptide Therapeutics Market, by Route of Administration, 2016-2026
        1. 7.3.5.1. North America Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
      6. 7.3.6. North America Peptide Therapeutics Market, by Synthesis Technology, 2016-2026
        1. 7.3.6.1. North America Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
      7. 7.3.7. North America Peptide Therapeutics Market, by Application, 2016-2026
        1. 7.3.7.1. North America Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
      8. 7.3.8. U.S.
        1. 7.3.8.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      9. 7.3.9. Canada
        1. 7.3.9.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 7.4. Europe
      1. 7.4.1. Europe Peptide Therapeutics Market size and forecast, 2016-2026
      2. 7.4.2. Europe Peptide Therapeutics Market, by Country, 2018 & 2025 (USD Million)
      3. 7.4.3. Europe Peptide Therapeutics Market, by Type, 2016-2026
        1. 7.4.3.1. Europe Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
      4. 7.4.4. Europe Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026
        1. 7.4.4.1. Europe Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
      5. 7.4.5. Europe Peptide Therapeutics Market, by Route of Administration, 2016-2026
        1. 7.4.5.1. Europe Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
      6. 7.4.6. Europe Peptide Therapeutics Market, by Synthesis Technology, 2016-2026
        1. 7.4.6.1. Europe Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
      7. 7.4.7. Europe Peptide Therapeutics Market, by Application, 2016-2026
        1. 7.4.7.1. Europe Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
      8. 7.4.8. Germany
        1. 7.4.8.1. Germany Market size and forecast, 2016-2026 (USD Million)
      9. 7.4.9. France
        1. 7.4.9.1. France Market size and forecast, 2016-2026 (USD Million)
      10. 7.4.10. U.K.
        1. 7.4.10.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      11. 7.4.11. Italy
        1. 7.4.11.1. Italy Market size and forecast, 2016-2026 (USD Million)
      12. 7.4.12. Spain
        1. 7.4.12.1. Spain Market size and forecast, 2016-2026 (USD Million)
      13. 7.4.13. Rest of Europe
        1. 7.4.13.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 7.5. Asia Pacific
      1. 7.5.1. Asia Pacific Peptide Therapeutics Market size and forecast, 2016-2026
      2. 7.5.2. Asia Pacific Peptide Therapeutics Market, by Country, 2018 & 2025 (USD Million)
      3. 7.5.3. Asia Pacific Peptide Therapeutics Market, by Type, 2016-2026
        1. 7.5.3.1. Asia Pacific Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
      4. 7.5.4. Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026
        1. 7.5.4.1. Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
      5. 7.5.5. Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2016-2026
        1. 7.5.5.1. Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
      6. 7.5.6. Asia Pacific Peptide Therapeutics Market, by Synthesis Technology, 2016-2026
        1. 7.5.6.1. Asia Pacific Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
      7. 7.5.7. Asia Pacific Peptide Therapeutics Market, by Application, 2016-2026
        1. 7.5.7.1. Asia Pacific Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
      8. 7.5.8. China
        1. 7.5.8.1. China Market size and forecast, 2016-2026 (USD Million)
      9. 7.5.9. Japan
        1. 7.5.9.1. Japan Market size and forecast, 2016-2026 (USD Million)
      10. 7.5.10. India
        1. 7.5.10.1. India Market size and forecast, 2016-2026 (USD Million)
      11. 7.5.11. South Korea
        1. 7.5.11.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      12. 7.5.12. South-East Asia
        1. 7.5.12.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      13. 7.5.13. Rest of Asia Pacific
        1. 7.5.13.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 7.6. Latin America
      1. 7.6.1. Latin America Peptide Therapeutics Market size and forecast, 2016-2026
      2. 7.6.2. Latin America Peptide Therapeutics Market, by Country, 2018 & 2025 (USD Million)
      3. 7.6.3. Latin America Peptide Therapeutics Market, by Type, 2016-2026
        1. 7.6.3.1. Latin America Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
      4. 7.6.4. Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026
        1. 7.6.4.1. Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
      5. 7.6.5. Latin America Peptide Therapeutics Market, by Route of Administration, 2016-2026
        1. 7.6.5.1. Latin America Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
      6. 7.6.6. Latin America Peptide Therapeutics Market, by Synthesis Technology, 2016-2026
        1. 7.6.6.1. Latin America Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
      7. 7.6.7. Latin America Peptide Therapeutics Market, by Application, 2016-2026
        1. 7.6.7.1. Latin America Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
      8. 7.6.8. Brazil
        1. 7.6.8.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      9. 7.6.9. Mexico
        1. 7.6.9.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      10. 7.6.10. Rest of Latin America
        1. 7.6.10.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 7.7. The Middle-East and Africa
      1. 7.7.1. The Middle-East and Africa Peptide Therapeutics Market size and forecast, 2016-2026
      2. 7.7.2. The Middle-East and Africa Peptide Therapeutics Market, by Country, 2018 & 2025 (USD Million)
      3. 7.7.3. The Middle-East and Africa Peptide Therapeutics Market, by Type, 2016-2026
        1. 7.7.3.1. The Middle-East and Africa Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
      4. 7.7.4. The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026
        1. 7.7.4.1. The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
      5. 7.7.5. The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2016-2026
        1. 7.7.5.1. The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
      6. 7.7.6. The Middle-East and Africa Peptide Therapeutics Market, by Synthesis Technology, 2016-2026
        1. 7.7.6.1. The Middle-East and Africa Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
      7. 7.7.7. The Middle-East and Africa Peptide Therapeutics Market, by Application, 2016-2026
        1. 7.7.7.1. The Middle-East and Africa Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
      8. 7.7.8. GCC Countries
        1. 7.7.8.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      9. 7.7.9. South Africa
        1. 7.7.9.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      10. 7.7.10. Rest of Middle-East Africa
        1. 7.7.10.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  8. CHAPTER 8. Peptide Therapeutics market – Competitive Landscape
    1. 8.1. Competitor Market Share – Revenue
    2. 8.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 8.3. Strategic Development
      1. 8.3.1. Acquisitions and Mergers
      2. 8.3.2. New Products
      3. 8.3.3. Research & Development Activities
  9. CHAPTER 9. Company Profiles
    1. 9.1. Eli Lilly and Company
      1. 9.1.1. Company Overview
      2. 9.1.2. Eli Lilly and Company Revenue and Gross Margin
      3. 9.1.3. Product portfolio
      4. 9.1.4. Recent initiatives
    2. 9.2. Pfizer Inc.
      1. 9.2.1. Company Overview
      2. 9.2.2. Pfizer Inc. Revenue and Gross Margin
      3. 9.2.3. Product portfolio
      4. 9.2.4. Recent initiatives
    3. 9.3. Amgen Inc.
      1. 9.3.1. Company Overview
      2. 9.3.2. Amgen Inc. Revenue and Gross Margin
      3. 9.3.3. Product portfolio
      4. 9.3.4. Recent initiatives
    4. 9.4. Takeda Pharmaceutical Company Limited
      1. 9.4.1. Company Overview
      2. 9.4.2. Takeda Pharmaceutical Company Limited Revenue and Gross Margin
      3. 9.4.3. Product portfolio
      4. 9.4.4. Recent initiatives
    5. 9.5. Teva Pharmaceuticals Industries Ltd.
      1. 9.5.1. Company Overview
      2. 9.5.2. Teva Pharmaceuticals Industries Ltd. Revenue and Gross Margin
      3. 9.5.3. Product portfolio
      4. 9.5.4. Recent initiatives
    6. 9.6. Lonza Inc.
      1. 9.6.1. Company Overview
      2. 9.6.2. Lonza Inc. Revenue and Gross Margin
      3. 9.6.3. Product portfolio
      4. 9.6.4. Recent initiatives
    7. 9.7. Sanofi
      1. 9.7.1. Company Overview
      2. 9.7.2. Sanofi Revenue and Gross Margin
      3. 9.7.3. Product portfolio
      4. 9.7.4. Recent initiatives
    8. 9.8. Bristol-Myers Squibb (BMS)
      1. 9.8.1. Company Overview
      2. 9.8.2. Bristol-Myers Squibb (BMS) Revenue and Gross Margin
      3. 9.8.3. Product portfolio
      4. 9.8.4. Recent initiatives
    9. 9.9. AstraZeneca PLC
      1. 9.9.1. Company Overview
      2. 9.9.2. AstraZeneca PLC Revenue and Gross Margin
      3. 9.9.3. Product portfolio
      4. 9.9.4. Recent initiatives
    10. 9.10. GlaxoSmithKline plc (GSK)
      1. 9.10.1. Company Overview
      2. 9.10.2. GlaxoSmithKline plc (GSK) Revenue and Gross Margin
      3. 9.10.3. Product portfolio
      4. 9.10.4. Recent initiatives
    11. 9.11. Novartis AG
      1. 9.11.1. Company Overview
      2. 9.11.2. Novartis AG Revenue and Gross Margin
      3. 9.11.3. Product portfolio
      4. 9.11.4. Recent initiatives
    12. 9.12. Novo Nordisk A/S
      1. 9.12.1. Company Overview
      2. 9.12.2. Novo Nordisk A/S Revenue and Gross Margin
      3. 9.12.3. Product portfolio
      4. 9.12.4. Recent initiatives
  10. CHAPTER 10. Peptide Therapeutics — Industry Analysis
    1. 10.1. Peptide Therapeutics Market – Key Trends
      1. 10.1.1. Market Drivers
      2. 10.1.2. Market Restraints
      3. 10.1.3. Market Opportunities
    2. 10.2. Value Chain Analysis
    3. 10.3. Technology Roadmap and Timeline
    4. 10.4. Peptide Therapeutics Market – Attractiveness Analysis
      1. 10.4.1. By Type
      2. 10.4.2. By Type of Manufacturers
      3. 10.4.3. By Route of Administration
      4. 10.4.4. By Synthesis Technology
      5. 10.4.5. By Application
      6. 10.4.6. By Region
  11. CHAPTER 11. Marketing Strategy Analysis, Distributors
    1. 11.1. Marketing Channel
    2. 11.2. Direct Marketing
    3. 11.3. Indirect Marketing
    4. 11.4. Marketing Channel Development Trend
    5. 11.5. Economic/Political Environmental Change
  12. CHAPTER 12. Report Conclusion
  13. CHAPTER 13. Research Approach & Methodology
    1. 13.1. Report Description
    2. 13.2. Research Scope
    3. 13.3. Research Methodology
      1. 13.3.1. Secondary Research
      2. 13.3.2. Primary Research
      3. 13.3.3. Models
        1. 13.3.3.1. Company Share Analysis Model
        2. 13.3.3.2. Revenue Based Modeling
        3. 13.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 2 Global Peptide Therapeutics Market Share, by Type, 2018 & 2025 (USD Million)
        FIG. 3 Global Generic Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 4 Global Innovative Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 5 Global Peptide Therapeutics Market Share, by Type of Manufacturers, 2018 & 2025 (USD Million)
        FIG. 6 Global In-house Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 7 Global Outsourced Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 8 Global Peptide Therapeutics Market Share, by Route of Administration, 2018 & 2025 (USD Million)
        FIG. 9 Global Parenteral Route Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 10 Global Oral Route Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 11 Global Pulmonary Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 12 Global Mucosal Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 13 Global Others Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 14 Global Peptide Therapeutics Market Share, by Synthesis Technology, 2018 & 2025 (USD Million)
        FIG. 15 Global Solid Phase Peptide Synthesis (SPPS) Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 16 Global Liquid Phase Peptide Synthesis (LPPS) Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 17 Global Hybrid Technology Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 18 Global Peptide Therapeutics Market Share, by Application, 2018 & 2025 (USD Million)
        FIG. 19 Global Metabolic Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 20 Global Cardiovascular Disorder Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 21 Global Respiratory Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 22 Global GIT Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 23 Global Anti-infection Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 24 Global Pain Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 25 Global Dermatology Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 26 Global CNS Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 27 Global Renal Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 28 Global Cancer Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 29 Global Others Peptide Therapeutics Market, 2016-2026 (USD Million)
        FIG. 30 Global Peptide Therapeutics Market Share, by Region, 2018 & 2025
        FIG. 31 North America Peptide Therapeutics Market, 2016-2026
        FIG. 32 U.S. Peptide Therapeutics Market, 2016-2026
        FIG. 33 Canada Peptide Therapeutics Market, 2016-2026
        FIG. 34 Europe Peptide Therapeutics Market, 2016-2026
        FIG. 35 Germany Peptide Therapeutics Market, 2016-2026
        FIG. 36 France Peptide Therapeutics Market, 2016-2026
        FIG. 37 U.K. Peptide Therapeutics Market, 2016-2026
        FIG. 38 Italy Peptide Therapeutics Market, 2016-2026
        FIG. 39 Spain Peptide Therapeutics Market, 2016-2026
        FIG. 40 Rest of Europe Peptide Therapeutics Market, 2016-2026
        FIG. 41 Asia Pacific Peptide Therapeutics Market, 2016-2026
        FIG. 42 China Peptide Therapeutics Market, 2016-2026
        FIG. 43 Japan Peptide Therapeutics Market, 2016-2026
        FIG. 44 India Peptide Therapeutics Market, 2016-2026
        FIG. 45 South  Korea Peptide Therapeutics Market, 2016-2026
        FIG. 46 South-East Asia Peptide Therapeutics Market, 2016-2026
        FIG. 47 Rest of Asia Pacific Peptide Therapeutics Market, 2016-2026
        FIG. 48 Latin America Peptide Therapeutics Market, 2016-2026
        FIG. 49 Brazil Peptide Therapeutics Market, 2016-2026
        FIG. 50 Mexico Peptide Therapeutics Market, 2016-2026
        FIG. 51 Rest of Latin America Peptide Therapeutics Market, 2016-2026
        FIG. 52 The Middle-East and Africa Peptide Therapeutics Market, 2016-2026
        FIG. 53 GCC Countries Peptide Therapeutics Market, 2016-2026
        FIG. 54 South Africa Peptide Therapeutics Market, 2016-2026
        FIG. 55 Rest of Middle-East Africa Peptide Therapeutics Market, 2016-2026
        FIG. 56 Competitor Market Share – Revenue
        FIG. 57 Eli Lilly and Company Revenue and Growth Rate
        FIG. 58 Eli Lilly and Company Market Share
        FIG. 59 Pfizer Inc. Revenue and Growth Rate
        FIG. 60 Pfizer Inc. Market Share
        FIG. 61 Amgen Inc. Revenue and Growth Rate
        FIG. 62 Amgen Inc. Market Share
        FIG. 63 Takeda Pharmaceutical Company Limited Revenue and Growth Rate
        FIG. 64 Takeda Pharmaceutical Company Limited Market Share
        FIG. 65 Teva Pharmaceuticals Industries Ltd. Revenue and Growth Rate
        FIG. 66 Teva Pharmaceuticals Industries Ltd. Market Share
        FIG. 67 Lonza Inc. Revenue and Growth Rate
        FIG. 68 Lonza Inc. Market Share
        FIG. 69 Sanofi Revenue and Growth Rate
        FIG. 70 Sanofi Market Share
        FIG. 71 Bristol-Myers Squibb (BMS) Revenue and Growth Rate
        FIG. 72 Bristol-Myers Squibb (BMS) Market Share
        FIG. 73 AstraZeneca PLC Revenue and Growth Rate
        FIG. 74 AstraZeneca PLC Market Share
        FIG. 75 GlaxoSmithKline plc (GSK) Revenue and Growth Rate
        FIG. 76 GlaxoSmithKline plc (GSK) Market Share
        FIG. 77 Novartis AG Revenue and Growth Rate
        FIG. 78 Novartis AG Market Share
        FIG. 79 Novo Nordisk A/S Revenue and Growth Rate
        FIG. 80 Novo Nordisk A/S Market Share
        FIG. 81 Market Dynamics
        FIG. 82 Global Peptide Therapeutics – Value Chain Analysis
        FIG. 83 Technology Roadmap and Timeline
        FIG. 84 Market Attractiveness Analysis – By Type
        FIG. 85 Market Attractiveness Analysis – By Type of Manufacturers
        FIG. 86 Market Attractiveness Analysis – By Route of Administration
        FIG. 87 Market Attractiveness Analysis – By Synthesis Technology
        FIG. 88 Market Attractiveness Analysis – By Application
        FIG. 89 Market Attractiveness Analysis – By Region
        FIG. 90 Market Channel
        FIG. 91 Marketing Channel Development Trend
        FIG. 92 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Peptide Therapeutics Market, 2018 & 2025 (USD Million)
        TABLE 2 Global Peptide Therapeutics market, by Type, 2016-2026 (USD Million)
        TABLE 3 Global Peptide Therapeutics market, by Type of Manufacturers, 2016-2026 (USD Million)
        TABLE 4 Global Peptide Therapeutics market, by Route of Administration, 2016-2026 (USD Million)
        TABLE 5 Global Peptide Therapeutics market, by Synthesis Technology, 2016-2026 (USD Million)
        TABLE 6 Global Peptide Therapeutics market, by Application, 2016-2026 (USD Million)
        TABLE 7 Global Peptide Therapeutics market, by Region, 2016-2026 (USD Million)
        TABLE 8 North America Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
        TABLE 9 North America Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
        TABLE 10 North America Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
        TABLE 11 North America Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
        TABLE 12 North America Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
        TABLE 13 Europe Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
        TABLE 14 Europe Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
        TABLE 15 Europe Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
        TABLE 16 Europe Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
        TABLE 17 Europe Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
        TABLE 18 Asia Pacific Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
        TABLE 19 Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
        TABLE 20 Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
        TABLE 21 Asia Pacific Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
        TABLE 22 Asia Pacific Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
        TABLE 23 Latin America Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
        TABLE 24 Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
        TABLE 25 Latin America Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
        TABLE 26 Latin America Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
        TABLE 27 Latin America Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
        TABLE 28 The Middle-East and Africa Peptide Therapeutics Market, by Type, 2016-2026 (USD Million)
        TABLE 29 The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2016-2026 (USD Million)
        TABLE 30 The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2016-2026 (USD Million)
        TABLE 31 The Middle-East and Africa Peptide Therapeutics Market, by Synthesis Technology, 2016-2026 (USD Million)
        TABLE 32 The Middle-East and Africa Peptide Therapeutics Market, by Application, 2016-2026 (USD Million)
        TABLE 33 Global Peptide Therapeutics Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 34 Global Peptide Therapeutics Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 35 Acquisitions and Mergers
        TABLE 36 New Product/Service Launch
        TABLE 37 Research & Development Activities
        TABLE 38 Market Drivers
        TABLE 39 Market Restraints
        TABLE 40 Market Opportunities

Industry Major Market Players

  •  Novartis AG
  •  Eli Lilly and Company
  •  Amgen Inc.
  •  Pfizer Inc.
  •  Lonza Inc.
  •  Teva Pharmaceuticals Industries Ltd.
  •  Sanofi
  •  GlaxoSmithKline plc.
  •  Bristol-Myers Squibb
  •  AstraZeneca PLC
  •  Takeda Pharmaceutical Company Limited
  •  Novo Nordisk A/S.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions